Susquehanna International Group’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-931
| Closed | -$9.87K | – | 6556 |
|
|
2023
Q4 | $9.87K | Buy |
931
+113
| +14% | +$1.2K | ﹤0.01% | 5740 |
|
|
2023
Q3 | $16.2K | Sell |
818
-2,442
| -75% | -$48.3K | ﹤0.01% | 5294 |
|
|
2023
Q2 | $249K | Sell |
3,260
-766
| -19% | -$58.6K | ﹤0.01% | 4420 |
|
|
2023
Q1 | $380K | Buy |
4,026
+772
| +24% | +$73K | ﹤0.01% | 4144 |
|
|
2022
Q4 | $317K | Sell |
3,254
-5,280
| -62% | -$514K | ﹤0.01% | 3831 |
|
|
2022
Q3 | $2.2M | Buy |
8,534
+869
| +11% | +$224K | ﹤0.01% | 1573 |
|
|
2022
Q2 | $1.43M | Buy |
7,665
+5,242
| +216% | +$975K | ﹤0.01% | 2049 |
|
|
2022
Q1 | $237K | Sell |
2,423
-2,915
| -55% | -$285K | ﹤0.01% | 4629 |
|
|
2021
Q4 | $873K | Sell |
5,338
-1,396
| -21% | -$228K | ﹤0.01% | 3031 |
|
|
2021
Q3 | $1.84M | Buy |
6,734
+1,001
| +17% | +$273K | ﹤0.01% | 2054 |
|
|
2021
Q2 | $2.27M | Buy |
5,733
+1,938
| +51% | +$767K | ﹤0.01% | 1944 |
|
|
2021
Q1 | $2.05M | Sell |
3,795
-3,558
| -48% | -$1.92M | ﹤0.01% | 2088 |
|
|
2020
Q4 | $2.78M | Sell |
7,353
-350
| -5% | -$132K | ﹤0.01% | 1446 |
|
|
2020
Q3 | $2.91M | Buy |
7,703
+1,197
| +18% | +$452K | ﹤0.01% | 1158 |
|
|
2020
Q2 | $3.2M | Sell |
6,506
-781
| -11% | -$384K | ﹤0.01% | 1103 |
|
|
2020
Q1 | $2.68M | Sell |
7,287
-7,479
| -51% | -$2.75M | ﹤0.01% | 1083 |
|
|
2019
Q4 | $10.5M | Buy |
14,766
+7,755
| +111% | +$5.49M | ﹤0.01% | 513 |
|
|
2019
Q3 | $4.5M | Buy |
7,011
+21
| +0.3% | +$13.5K | ﹤0.01% | 709 |
|
|
2019
Q2 | $6.11M | Sell |
6,990
-1,093
| -14% | -$956K | ﹤0.01% | 591 |
|
|
2019
Q1 | $4.67M | Sell |
8,083
-513
| -6% | -$296K | ﹤0.01% | 451 |
|
|
2018
Q4 | $2.41M | Buy |
8,596
+4,194
| +95% | +$1.18M | ﹤0.01% | 837 |
|
|
2018
Q3 | $2.11M | Sell |
4,402
-803
| -15% | -$385K | ﹤0.01% | 942 |
|
|
2018
Q2 | $2.36M | Sell |
5,205
-905
| -15% | -$410K | ﹤0.01% | 923 |
|
|
2018
Q1 | $3.59M | Sell |
6,110
-4,883
| -44% | -$2.87M | ﹤0.01% | 643 |
|
|
2017
Q4 | $6.83M | Sell |
10,993
-23,435
| -68% | -$14.6M | ﹤0.01% | 451 |
|
|
2017
Q3 | $31.7M | Sell |
34,428
-18,217
| -35% | -$16.8M | 0.01% | 132 |
|
|
2017
Q2 | $49.1M | Buy |
52,645
+48,800
| +1,269% | +$45.5M | 0.02% | 90 |
|
|
2017
Q1 | $3.66M | Sell |
3,845
-8,288
| -68% | -$7.88M | ﹤0.01% | 613 |
|
|
2016
Q4 | $9.74M | Buy |
12,133
+2,523
| +26% | +$2.02M | ﹤0.01% | 282 |
|
|
2016
Q3 | $8.12M | Sell |
9,610
-600
| -6% | -$507K | ﹤0.01% | 252 |
|
|
2016
Q2 | $8.41M | Sell |
10,210
-1,109
| -10% | -$913K | ﹤0.01% | 265 |
|
|
2016
Q1 | $12.6M | Sell |
11,319
-8,621
| -43% | -$9.6M | 0.01% | 270 |
|
|
2015
Q4 | $24.9M | Buy |
19,940
+5,329
| +36% | +$6.64M | 0.01% | 214 |
|
|
2015
Q3 | $19.7M | Buy |
14,611
+4,397
| +43% | +$5.94M | 0.01% | 280 |
|
|
2015
Q2 | $18.4M | Buy |
10,214
+6,157
| +152% | +$11.1M | 0.01% | 352 |
|
|
2015
Q1 | $6.55M | Sell |
4,057
-266
| -6% | -$430K | ﹤0.01% | 684 |
|
|
2014
Q4 | $3.29M | Buy |
4,323
+367
| +9% | +$279K | ﹤0.01% | 1392 |
|
|
2014
Q3 | $1.57M | Buy |
3,956
+275
| +7% | +$109K | ﹤0.01% | 1926 |
|
|
2014
Q2 | $2.23M | Buy |
3,681
+1,830
| +99% | +$1.11M | ﹤0.01% | 1634 |
|
|
2014
Q1 | $1.27M | Sell |
1,851
-6,465
| -78% | -$4.44M | ﹤0.01% | 1894 |
|
|
2013
Q4 | $5.41M | Buy |
8,316
+3,917
| +89% | +$2.55M | ﹤0.01% | 979 |
|
|
2013
Q3 | $2.61M | Buy |
4,399
+222
| +5% | +$132K | ﹤0.01% | 1293 |
|
|
2013
Q2 | $1.32M | Buy |
+4,177
| New | +$1.32M | ﹤0.01% | 1805 |
|